Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Culturing microbial dark matter to discover novel antimicrobials and bioactives
Bactobio is a biotechnology company using synthetic biology, next-generation sequencing, and machine learning to culture the vast majority of environmental microbes that have…
Native mass spectrometry platform for small molecule drug discovery
OMass Therapeutics is a biotechnology company developing small molecule therapeutics against membrane proteins, GPCRs, and intracellular complexes that have historically been…
Clinical-stage oncology biopharma developing the bispecific antibody ivonescimab
Summit Therapeutics is a clinical-stage oncology company with UK research operations originating from VASTox, a University of Oxford spin-out. The company's lead candidate,…
CRISPR-based Guided Biotics platform for precision microbiome modulation
FOLIUM Science is a biotech developing a patented CRISPR-Cas platform that selectively silences genes in target bacteria to modulate animal and food microbiomes without disrupting…
AI-driven precision therapeutics for metabolic syndrome diseases
Multiomic Health is a data-centric therapeutics company developing precision medicines for metabolic syndrome-related conditions, including type 2 diabetes, cardiovascular…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and…
Probiotic contract manufacturer and Lab4 platform developer
Cultech is a Welsh contract developer and manufacturer of probiotic and nutritional supplement products, operating one of the world's most advanced probiotic manufacturing…
Gene therapy biotech targeting neural circuit dysfunction
Sania Therapeutics is a biotechnology company developing genetic medicines for diseases caused by dysfunctional neural circuits. Its approach combines precision AAV delivery to…
Mechanobiology platform for target discovery and validation
Mechanome Bio is a Cambridge-based company developing a mechano-transcriptomics platform for biomarker and drug target discovery. The platform combines spatial multi-omics data…
Reprogrammed stem cell therapies for vascular disease and chronic wounds
ReproGo is a Belfast-based regenerative medicine company developing Advanced Therapy Medicinal Products through direct cell reprogramming of adult cells into vascular lineages.…
Non-viral intracellular drug delivery for solid tumours
Vitarka Therapeutics is a preclinical biotech company developing a non-viral drug delivery platform for targeted intracellular delivery of therapeutics to solid tumours. The…
Ophthalmic therapeutics for presbyopia, cataracts, and geographic atrophy
Tenpoint Therapeutics is a clinical-stage biotechnology company developing therapeutics for age-related ocular diseases. Its pipeline comprises three programmes: BRIMOCHOL PF, a…